Pharma companies aim to halve CAR-T therapy production time
Big pharma giants are cutting CAR-T therapy manufacturing time to expand access for aggressive cancer patients, aiming for faster, life-extending treatments.
Addressing the economic impact of sick days in South Africa
Sick days cost the economy an estimated R19 billion annually. Do South African employees need more support to stay healthy and productive at work?
SA’s groundbreaking HIV research on elite controllers
South Africa's research on elite controllers uncovers unique genetic factors in HIV control, promising new treatments and vaccines for African populations.
US pharmaceutical industry intermediaries defend their role
Pharmacy benefit managers defended their roles in a Congressional hearing amid accusations of promoting expensive treatments. Executives claimed their models save money, while a report highlighted anti-competitive practices and high drug prices.
Gauteng Cancer Backlog: 3,000 Patients Awaiting Care
Understand the Gauteng cancer backlog controversy, where legal actions aim to expedite radiation therapy for 3,000 awaiting patients.